[IgG subclasses in chronic brucellosis patients].

Area of Science:

• Immunology
• Infectious Diseases
• Clinical Medicine

Background:

• Brucellosis is a persistent infectious disease affecting multiple organ systems.
• Immunoglobulin levels, particularly IgG subclasses, can be altered in chronic infections.
• Understanding these alterations is crucial for effective disease management and therapeutic strategies.

Purpose of the Study:

• To analyze immunoglobulin (IgA, IgM, IgG) and IgG subclass (IgG1, IgG2, IgG3, IgG4) levels in patients with chronic brucellosis.
• To investigate the changes in immunoglobulin levels following therapeutic vaccination in these patients.
• To explore the correlation between IgG levels and specific antibody resistance.

Main Methods:

• Serum samples from 52 chronic brucellosis patients (1-10 years duration) were analyzed.
• Immunoglobulin levels (IgA, IgM, IgG, and IgG subclasses) were quantified.
• Levels were compared before and after therapeutic vaccination in a subset of 10 patients.

Main Results:

• Chronic brucellosis patients exhibited normal levels of IgG1, IgG2, and IgG4, but elevated IgG3.
• A correlation was observed between increased total IgG levels and 2-mercaptoethanol-resistant specific antibodies.
• Vaccinal therapy led to increased total IgG and IgG1, a decrease in IgG3, with IgG2 and IgG4 remaining stable.

Conclusions:

• Chronic brucellosis is associated with a specific pattern of IgG subclass dysregulation, notably elevated IgG3.
• Therapeutic vaccination modulates immunoglobulin levels, suggesting an impact on the immune response to brucellosis.
• Further research into these immune changes could inform the development of improved diagnostic and therapeutic approaches.